CirChem AB
STO:CIRCHE

Watchlist Manager

CirChem AB

STO:CIRCHE

Watchlist

Dividends

Discount Rate

Price: 2.6 SEK -1.89%

Market Cap: 81m SEK

Have any thoughts about
CirChem AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 2.6 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CIRCHE Alert

CirChem AB

2.6

-0.05 (-1.89%)

52 Week Range	2.19 3.76
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

CirChem AB

What unique competitive advantages
does CirChem AB hold over its rivals?

What risks and challenges
does CirChem AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of CirChem AB.

What unique competitive advantages
does CirChem AB hold over its rivals?

What risks and challenges
does CirChem AB face in the near future?

Has there been any significant insider trading activity
in CirChem AB recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CirChem AB.

Provide P/S
for CirChem AB.

Provide P/E
for CirChem AB.

Provide P/OCF
for CirChem AB.

Provide P/FCFE
for CirChem AB.

Provide P/B
for CirChem AB.

Provide EV/S
for CirChem AB.

Provide EV/GP
for CirChem AB.

Provide EV/EBITDA
for CirChem AB.

Provide EV/EBIT
for CirChem AB.

Provide EV/OCF
for CirChem AB.

Provide EV/FCFF
for CirChem AB.

Provide EV/IC
for CirChem AB.

Compare the intrinsic valuations
of CirChem AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CirChem AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of CirChem AB compared to its peers.

Compare the P/E ratios
of CirChem AB against its peers.

Discuss the investment returns and shareholder value creation
comparing CirChem AB with its peers.

Analyze the financial leverage
of CirChem AB compared to its main competitors.

Show all profitability ratios
for CirChem AB.

Provide ROE
for CirChem AB.

Provide ROA
for CirChem AB.

Provide ROIC
for CirChem AB.

Provide ROCE
for CirChem AB.

Provide Gross Margin
for CirChem AB.

Provide Operating Margin
for CirChem AB.

Provide Net Margin
for CirChem AB.

Provide FCF Margin
for CirChem AB.

Show all solvency ratios
for CirChem AB.

Provide D/E Ratio
for CirChem AB.

Provide D/A Ratio
for CirChem AB.

Provide Interest Coverage Ratio
for CirChem AB.

Provide Altman Z-Score Ratio
for CirChem AB.

Provide Quick Ratio
for CirChem AB.

Provide Current Ratio
for CirChem AB.

Provide Cash Ratio
for CirChem AB.

What is the historical Revenue growth
over the last 5 years for CirChem AB?

What is the historical Net Income growth
over the last 5 years for CirChem AB?

What is the current Free Cash Flow
of CirChem AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for CirChem AB.

CIRCHE

Balance Sheet

Total Current Liabilities

CirChem AB
Total Current Liabilities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

CirChem AB
Total Current Liabilities Peer Comparison

Comparables:

NEXAM

DURC B

ARPL

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company		Total Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
C	CirChem AB STO:CIRCHE	Total Current Liabilities kr15.1m	CAGR 3-Years 25%	CAGR 5-Years 20%	CAGR 10-Years N/A
N	Nexam Chemical Holding AB STO:NEXAM	Total Current Liabilities kr43.7m	CAGR 3-Years -12%	CAGR 5-Years 4%	CAGR 10-Years 25%
	Duroc AB STO:DURC B	Total Current Liabilities kr524.4m	CAGR 3-Years -7%	CAGR 5-Years -6%	CAGR 10-Years N/A
	Arla Plast AB STO:ARPL	Total Current Liabilities kr150.7m	CAGR 3-Years 2%	CAGR 5-Years -4%	CAGR 10-Years N/A

What is CirChem AB's Total Current Liabilities?

Total Current Liabilities
15.1m SEK

Based on the financial report for Dec 31, 2023, CirChem AB's Total Current Liabilities amounts to 15.1m SEK.

What is CirChem AB's Total Current Liabilities growth rate?

Total Current Liabilities CAGR 5Y
20%

Over the last year, the Total Current Liabilities growth was -36%. The average annual Total Current Liabilities growth rates for CirChem AB have been 25% over the past three years , 20% over the past five years .

CirChem AB
STO:CIRCHE

CirChem AB
Total Current Liabilities

CirChem AB
Total Current Liabilities Peer Comparison

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

See Also

What is CirChem AB's Total Current Liabilities?

Total Current Liabilities
15.1m SEK

What is CirChem AB's Total Current Liabilities growth rate?

Total Current Liabilities CAGR 5Y
20%

Company

Help

Tools

Stocks

CirChem AB STO:CIRCHE

CirChem AB Total Current Liabilities

CirChem AB Total Current Liabilities Peer Comparison

Competitive Total Current Liabilities Analysis Latest Figures & CAGR of Competitors

See Also

What is CirChem AB's Total Current Liabilities? Total Current Liabilities 15.1m SEK

What is CirChem AB's Total Current Liabilities growth rate? Total Current Liabilities CAGR 5Y 20%

Company

Help

Tools

Stocks

CirChem AB
STO:CIRCHE

CirChem AB
Total Current Liabilities

CirChem AB
Total Current Liabilities Peer Comparison

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

What is CirChem AB's Total Current Liabilities?

Total Current Liabilities
15.1m SEK

What is CirChem AB's Total Current Liabilities growth rate?

Total Current Liabilities CAGR 5Y
20%